Hemodialysis Complication: Clinical Trials

12 trials for Hemodialysis Complication, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 1 unknown. 12 Phase 2, 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 212Completed 11, Unknown 1
Phase 36Completed 5, Unknown 1

Follow Hemodialysis Complication: new trials by email Literature Review of Hemodialysis Complication trials Research Report on Hemodialysis Complication

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mupirocin 2% Ointment Vs Spray Antibiotics on Temporary Hemodialysis Catheter
Local antibiotic spray Neomycin sulphate 165,000 IU + Bacitracin zinc 12,500 IU, Mupirocin 2% ointment - Hemodialysis Complication, Hemodialysis Catheter Infection
Phase 2 / Phase 3CompletedFuture University in Egypt1502023-04-102023-08-22
Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease
L-Carnitine 500Mg thrice daily, 1g L-Carnitine IV three times a week - Hemodialysis Complication
Phase 2 / Phase 3CompletedBahria University832023-01-012024-08-09
Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease
Lanadelumab Injection [Takhzyro], Placebo - Hemodialysis Complication, Hypotension of Hemodialysis
Phase 2CompletedVanderbilt University Medical Center282022-07-272026-08-19
Cholecalciferol Supplementation in Hemodialysis Patients
Cholecalciferol - Anemia, Hemodialysis Complication
Phase 2 / Phase 3CompletedAin Shams University502022-05-152023-06-28
Study of Apixaban in Patients Receiving Hemodiafiltration
Apixaban 2.5 milligram Oral Tablet - Atrial Fibrillation, Hemodialysis Complication
Phase 2CompletedHospital Universitari de Bellvitge112021-05-202023-09-21
MAnnitol for Blood Pressure Stability in HemoDialysis (MAP-HD)
Mannitol, 0.9% saline - Hemodialysis Complication, Hemodynamic Instability
Phase 2 / Phase 3CompletedBrigham and Women's Hospital312021-04-062025-11-24
Regional Anticoagulation of Dialysis Circuits With a Calcium-free Citrate-containing Dialysate
anticoagulation of the dialysis circuit - Hemodialysis Complication, Bleeding
Phase 2CompletedUniversity Hospital, Toulouse972019-07-052025-12-15
Sildenafil in Hemodialysis Patients With Pulmonary Hypertension
Sildenafil, Placebo - Pulmonary Hypertension, Hemodialysis Complication
Phase 2 / Phase 3UnknownAin Shams University602018-12-022019-01-09
Cholecalciferol on Hemodialysis Patients
Cholecalciferol, Placebo - Hemodialysis Complication, Vitamin D Deficiency
Phase 2 / Phase 3CompletedAin Shams University602018-07-012019-01-09
Strategies for Asymmetrical Triacetate Dialyzer Heparin-Free Effective Hemodialysis
dialyzer, hemodialysis with citrate-containing dialysate, predilution hemodiafiltration - Hemodialysis Complication
Phase 2CompletedUniversitaire Ziekenhuizen KU Leuven202018-01-062020-05-21
Dialysate Sodium Lowering Trial
Dialysate Sodium Lowering - Hemodialysis Complication, Fluid Overload
Phase 2CompletedTufts Medical Center442017-04-262019-06-03
An Innovative Virtually Supervised Exercise for Dialysis Patients
Sensor-based interactive exercise (game-based exercise), Non-technology foot and ankle exercise program - Diabetes, Chronic Kidney Failure
Phase 2CompletedBaylor College of Medicine1002016-11-062019-05-06

Narrower conditions

Thrombosis (2)  ·  Vitamin D Deficiency (2)  ·  Anemia (1)  ·  Atrial Fibrillation (1)  ·  Diabetes Mellitus (1)  ·  Dysequilibrium syndrome (1)  ·  Edema (1)  ·  Hemorrhage (1)  ·  Hypertension (1)  ·  Hypertension, Pulmonary (1)  ·  Kidney Failure, Chronic (1)  ·  Motor Activity (1)  ·  Renal Insufficiency, Chronic (1)  ·  Vascular Calcification (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Pathologic Processes (4)  ·  Vascular Diseases (4)  ·  Nutritional and Metabolic Diseases (3)  ·  Avitaminosis (2)  ·  Chronic Disease (2)  ·  Deficiency Diseases (2)  ·  Disease Attributes (2)  ·  Embolism and Thrombosis (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Malnutrition (2)

Interventions

Cholecalciferol (2)  ·  Bacitracin (1)  ·  Carnitine (1)  ·  Citric Acid (1)  ·  Kidneys, Artificial (1)  ·  Mannitol (1)  ·  Mupirocin (1)  ·  Ointments (1)  ·  Renal Dialysis (1)  ·  Saline Solution (1)  ·  Sildenafil Citrate (1)  ·  lanadelumab (1)

Sponsors

Ain Shams University (3)  ·  Bahria University (1)  ·  Baylor College of Medicine (1)  ·  Brigham and Women's Hospital (1)  ·  Future University in Egypt (1)  ·  Hospital Universitari de Bellvitge (1)  ·  Tufts Medical Center (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  University Hospital, Toulouse (1)  ·  Vanderbilt University Medical Center (1)

Countries

Egypt (4)  ·  United States (3)  ·  Belgium (1)  ·  France (1)  ·  Pakistan (1)  ·  Qatar (1)  ·  Spain (1)

Top investigators

Dana Miskulin, MD (1)  ·  Doaa ElBohy, PhD (1)  ·  Finnian R Mc Causland, MBBCH, MMSc (1)  ·  Sadia Rehman (1)  ·  Tamer W Elsaid, MD (1)

Results publications

PMID 24525835, PMID 30353121, PMID 30441843, PMID 33139659, PMID 33594986, PMID 33713287, PMID 34740538, PMID 38189593, PMID 38977911, PMID 39498822, PMID 39763581

NIH funding

2018 (1)